Insiders EirGenix Inc.

Equities

6589

TW0006589005

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-07-10 pm EDT			5-day change	1st Jan Change
90.5 ^TWD	-2.06%		-3.62%	-9.95%

Jun. 14	Sandoz AG Re-Submits the Biosimilar Drug EG12014 (Trastuzumab Biosimilar) 150 Mg Powder BLA to the US FDA	CI
May. 15	EirGenix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

EirGenix Inc. Announces Executive Changes	23-01-10	CI
Eirgenix Inc. Announces Establishment of Corporate Governance Committee	22-12-28	CI
EirGenix Inc. Appoints Po-Chih Chen as Remuneration Committee	22-09-08	CI
EirGenix Inc. Announces Board Changes	22-09-07	CI
EirGenix Inc. Announces Management Changes	22-06-10	CI
EirGenix Inc. Announces Board Appointments	22-06-10	CI
EirGenix Inc. Announces Replacement of Representative of Juristic Person as Director	22-03-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer